Hepatitis C elimination in people living with HIV - the importance of biomedical and behavioural interventions.

van Santen DK, Sacks-Davis R, Hellard M

Hepatitis C HIV + AIDS

Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.

van Santen DK, Sacks-Davis R, Doyle JS, Scott N, Prins M, Hellard M

Injection drug network characteristics as a predictor of injection behaviour.

Spelman T, Sacks-Davis R, Dietze P, Higgs P, Hellard M

Australia needs to increase testing to achieve hepatitis C elimination.

Scott N, Sacks-Davis R, Wade AJ, Stoove M, Pedrana A, Doyle JS, Thompson AJ, Wilson DP, Hellard ME

Commentary on Barré et al. (2020): Identifying remaining barriers to hepatitis C treatment in the DAA era.

Sacks-Davis R, van Santen DK, Doyle JS

Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

Sacks-Davis R, Doyle JS, Rauch A, Beguelin C, Pedrana AE, Matthews GV, Prins M, van der Valk M, Klein MB, Saeed S, Lacombe K, Chkhartishvili N, Altice FL, Hellard ME